DGI Clinical Inc.: federal grants and contributions: 8 agreements; $1.2M value; 2 departments; 3 programs.
Assay record ASY-CA-0ZK89BU1Q1 · Cite as: Assay Systems, “DGI Clinical Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/dgi-clinical-inc/
Development of the GoalNav Platform, a clinical trial system for patient-centric outcomes measurement. This data capture system will be robust, secure, and scalable, supporting multiple simultaneous studies, across a mix of therapeutic areas.
The project will develop, refine, and validate two new analytical tools that can be used to expand the Firm's analytical service offerings.
Development of SymptomGuide(TM), an innovative clinical metrics software application
DGI Clinical plans to expand our services and tools to new clients in the pharmaceutical and medical device industry in the USA and Europe.
Development of a system for patient-centric research using Goal Attainment Scaling (GAS). In addition, the Firm seeks to better understand the opportunity for a GAS-based approach to clinical care.
This project will inform DGI’s product strategy, R&D program, and product roadmap. Key aspects include in-depth market research and the scoping of technical and financial investment required for DGI to navigate a strategic pivot.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.